nodes	percent_of_prediction	percent_of_DWPC	metapath
Dapiprazole—Risperidone—HTR7—coronary artery disease	0.0138	0.666	CrCbGaD
Dapiprazole—Risperidone—HTR2A—coronary artery disease	0.00694	0.335	CrCbGaD
Dapiprazole—ADRA1A—Signaling by GPCR—PPP2CA—coronary artery disease	0.000149	0.000152	CbGpPWpGaD
Dapiprazole—ADRA1A—Signaling Pathways—CCL3—coronary artery disease	0.000148	0.000151	CbGpPWpGaD
Dapiprazole—ADRA1A—Signaling Pathways—CXCL2—coronary artery disease	0.000148	0.000151	CbGpPWpGaD
Dapiprazole—ADRA1B—Signaling Pathways—PLAT—coronary artery disease	0.000147	0.00015	CbGpPWpGaD
Dapiprazole—ADRA1D—Signaling Pathways—ADRB2—coronary artery disease	0.000147	0.00015	CbGpPWpGaD
Dapiprazole—ADRA1A—Signaling Pathways—SDC1—coronary artery disease	0.000146	0.00015	CbGpPWpGaD
Dapiprazole—ADRA1A—Signaling Pathways—F2R—coronary artery disease	0.000146	0.00015	CbGpPWpGaD
Dapiprazole—ADRA1A—Signaling by GPCR—PRKCD—coronary artery disease	0.000146	0.000149	CbGpPWpGaD
Dapiprazole—ADRA1D—Signaling Pathways—PRKCE—coronary artery disease	0.000145	0.000148	CbGpPWpGaD
Dapiprazole—ADRA1D—GPCR downstream signaling—JAK2—coronary artery disease	0.000145	0.000148	CbGpPWpGaD
Dapiprazole—ADRA1D—Signaling Pathways—SOCS1—coronary artery disease	0.000144	0.000147	CbGpPWpGaD
Dapiprazole—ADRA1D—Signaling Pathways—S100B—coronary artery disease	0.000144	0.000147	CbGpPWpGaD
Dapiprazole—ADRA1A—Signaling Pathways—FGB—coronary artery disease	0.000143	0.000146	CbGpPWpGaD
Dapiprazole—ADRA1A—Signaling by GPCR—HTR2A—coronary artery disease	0.000143	0.000146	CbGpPWpGaD
Dapiprazole—ADRA1A—Signaling by GPCR—C3—coronary artery disease	0.000143	0.000146	CbGpPWpGaD
Dapiprazole—ADRA1D—Signaling Pathways—SOCS3—coronary artery disease	0.000143	0.000146	CbGpPWpGaD
Dapiprazole—ADRA1A—Signaling Pathways—EDNRB—coronary artery disease	0.000142	0.000145	CbGpPWpGaD
Dapiprazole—ADRA1B—Signaling Pathways—CXCL12—coronary artery disease	0.000142	0.000145	CbGpPWpGaD
Dapiprazole—ADRA1B—Signaling Pathways—BDKRB2—coronary artery disease	0.000142	0.000145	CbGpPWpGaD
Dapiprazole—ADRA1B—GPCR downstream signaling—POMC—coronary artery disease	0.000142	0.000145	CbGpPWpGaD
Dapiprazole—ADRA1B—Signaling by GPCR—F2—coronary artery disease	0.000141	0.000144	CbGpPWpGaD
Dapiprazole—ADRA1D—Signaling Pathways—TGFBR2—coronary artery disease	0.000141	0.000144	CbGpPWpGaD
Dapiprazole—ADRA1D—Signaling Pathways—KITLG—coronary artery disease	0.000141	0.000144	CbGpPWpGaD
Dapiprazole—ADRA1B—Signaling by GPCR—IL6ST—coronary artery disease	0.000141	0.000144	CbGpPWpGaD
Dapiprazole—ADRA1A—Signaling Pathways—THBS1—coronary artery disease	0.00014	0.000143	CbGpPWpGaD
Dapiprazole—ADRA1B—Signaling Pathways—JUNB—coronary artery disease	0.000139	0.000142	CbGpPWpGaD
Dapiprazole—ADRA1B—Signaling Pathways—PLCB1—coronary artery disease	0.000139	0.000142	CbGpPWpGaD
Dapiprazole—ADRA1A—Signaling Pathways—PSMA6—coronary artery disease	0.000138	0.000141	CbGpPWpGaD
Dapiprazole—ADRA1A—Signaling Pathways—PSMB5—coronary artery disease	0.000138	0.000141	CbGpPWpGaD
Dapiprazole—ADRA1A—GPCR downstream signaling—F2—coronary artery disease	0.000138	0.000141	CbGpPWpGaD
Dapiprazole—ADRA1D—Signaling Pathways—STAT5A—coronary artery disease	0.000138	0.000141	CbGpPWpGaD
Dapiprazole—ADRA1D—Signaling Pathways—MMP3—coronary artery disease	0.000138	0.000141	CbGpPWpGaD
Dapiprazole—ADRA1B—Signaling Pathways—HTR7—coronary artery disease	0.000136	0.000139	CbGpPWpGaD
Dapiprazole—ADRA1A—Signaling by GPCR—AGT—coronary artery disease	0.000136	0.000139	CbGpPWpGaD
Dapiprazole—ADRA1A—Signaling Pathways—EDNRA—coronary artery disease	0.000134	0.000137	CbGpPWpGaD
Dapiprazole—ADRA1A—Signaling Pathways—ADRB1—coronary artery disease	0.000133	0.000136	CbGpPWpGaD
Dapiprazole—ADRA1A—Signaling Pathways—CYBA—coronary artery disease	0.000133	0.000136	CbGpPWpGaD
Dapiprazole—ADRA1D—Signaling Pathways—APOB—coronary artery disease	0.000133	0.000136	CbGpPWpGaD
Dapiprazole—ADRA1A—Signaling Pathways—DUSP6—coronary artery disease	0.000133	0.000136	CbGpPWpGaD
Dapiprazole—ADRA1D—GPCR downstream signaling—CXCL8—coronary artery disease	0.000132	0.000135	CbGpPWpGaD
Dapiprazole—ADRA1D—Signaling by GPCR—JAK2—coronary artery disease	0.000131	0.000134	CbGpPWpGaD
Dapiprazole—ADRA1D—Signaling Pathways—EDN1—coronary artery disease	0.000131	0.000134	CbGpPWpGaD
Dapiprazole—ADRA1A—Signaling Pathways—PLAT—coronary artery disease	0.000131	0.000133	CbGpPWpGaD
Dapiprazole—ADRA1D—Signaling Pathways—CCL5—coronary artery disease	0.00013	0.000133	CbGpPWpGaD
Dapiprazole—ADRA1B—Signaling Pathways—ITGAV—coronary artery disease	0.000129	0.000132	CbGpPWpGaD
Dapiprazole—ADRA1B—Signaling Pathways—KNG1—coronary artery disease	0.000129	0.000132	CbGpPWpGaD
Dapiprazole—ADRA1B—Signaling by GPCR—POMC—coronary artery disease	0.000129	0.000131	CbGpPWpGaD
Dapiprazole—ADRA1B—Signaling by GPCR—CREB1—coronary artery disease	0.000129	0.000131	CbGpPWpGaD
Dapiprazole—ADRA1B—Signaling Pathways—AGTR1—coronary artery disease	0.000128	0.000131	CbGpPWpGaD
Dapiprazole—ADRA1D—Signaling Pathways—CSF2—coronary artery disease	0.000128	0.000131	CbGpPWpGaD
Dapiprazole—ADRA1D—Signaling Pathways—FGF1—coronary artery disease	0.000128	0.000131	CbGpPWpGaD
Dapiprazole—ADRA1D—Signaling Pathways—LPL—coronary artery disease	0.000127	0.00013	CbGpPWpGaD
Dapiprazole—ADRA1D—Signaling Pathways—MEF2C—coronary artery disease	0.000126	0.000129	CbGpPWpGaD
Dapiprazole—ADRA1A—Signaling Pathways—BDKRB2—coronary artery disease	0.000126	0.000129	CbGpPWpGaD
Dapiprazole—ADRA1A—Signaling Pathways—CXCL12—coronary artery disease	0.000126	0.000129	CbGpPWpGaD
Dapiprazole—ADRA1D—Signaling Pathways—RPS6KB1—coronary artery disease	0.000126	0.000129	CbGpPWpGaD
Dapiprazole—ADRA1B—Signaling by GPCR—CCL2—coronary artery disease	0.000126	0.000128	CbGpPWpGaD
Dapiprazole—ADRA1A—GPCR downstream signaling—POMC—coronary artery disease	0.000126	0.000128	CbGpPWpGaD
Dapiprazole—ADRA1B—Signaling by GPCR—IL6R—coronary artery disease	0.000125	0.000128	CbGpPWpGaD
Dapiprazole—ADRA1A—Signaling by GPCR—F2—coronary artery disease	0.000125	0.000128	CbGpPWpGaD
Dapiprazole—ADRA1B—Signaling Pathways—CXCL10—coronary artery disease	0.000125	0.000128	CbGpPWpGaD
Dapiprazole—ADRA1B—Signaling Pathways—PLG—coronary artery disease	0.000125	0.000128	CbGpPWpGaD
Dapiprazole—ADRA1A—Signaling by GPCR—IL6ST—coronary artery disease	0.000125	0.000128	CbGpPWpGaD
Dapiprazole—ADRA1A—Signaling Pathways—JUNB—coronary artery disease	0.000124	0.000126	CbGpPWpGaD
Dapiprazole—ADRA1A—Signaling Pathways—PLCB1—coronary artery disease	0.000123	0.000126	CbGpPWpGaD
Dapiprazole—ADRA1D—Signaling Pathways—ITGB3—coronary artery disease	0.000123	0.000125	CbGpPWpGaD
Dapiprazole—ADRA1B—Signaling Pathways—ADRB2—coronary artery disease	0.000122	0.000124	CbGpPWpGaD
Dapiprazole—ADRA1A—Signaling Pathways—HTR7—coronary artery disease	0.000121	0.000123	CbGpPWpGaD
Dapiprazole—ADRA1B—Signaling Pathways—PRKCE—coronary artery disease	0.00012	0.000123	CbGpPWpGaD
Dapiprazole—ADRA1B—GPCR downstream signaling—JAK2—coronary artery disease	0.00012	0.000123	CbGpPWpGaD
Dapiprazole—ADRA1D—Signaling by GPCR—CXCL8—coronary artery disease	0.00012	0.000122	CbGpPWpGaD
Dapiprazole—ADRA1B—Signaling Pathways—SOCS1—coronary artery disease	0.00012	0.000122	CbGpPWpGaD
Dapiprazole—ADRA1B—Signaling Pathways—S100B—coronary artery disease	0.00012	0.000122	CbGpPWpGaD
Dapiprazole—ADRA1D—Signaling Pathways—PPP2CA—coronary artery disease	0.000119	0.000122	CbGpPWpGaD
Dapiprazole—ADRA1B—Signaling Pathways—SOCS3—coronary artery disease	0.000118	0.000121	CbGpPWpGaD
Dapiprazole—ADRA1D—Signaling Pathways—PRKCD—coronary artery disease	0.000117	0.00012	CbGpPWpGaD
Dapiprazole—ADRA1B—Signaling Pathways—TGFBR2—coronary artery disease	0.000117	0.000119	CbGpPWpGaD
Dapiprazole—ADRA1B—Signaling Pathways—KITLG—coronary artery disease	0.000117	0.000119	CbGpPWpGaD
Dapiprazole—ADRA1A—Signaling Pathways—ITGAV—coronary artery disease	0.000115	0.000117	CbGpPWpGaD
Dapiprazole—ADRA1A—Signaling Pathways—KNG1—coronary artery disease	0.000115	0.000117	CbGpPWpGaD
Dapiprazole—ADRA1D—Signaling Pathways—HTR2A—coronary artery disease	0.000115	0.000117	CbGpPWpGaD
Dapiprazole—ADRA1D—Signaling Pathways—C3—coronary artery disease	0.000114	0.000117	CbGpPWpGaD
Dapiprazole—ADRA1B—Signaling Pathways—STAT5A—coronary artery disease	0.000114	0.000117	CbGpPWpGaD
Dapiprazole—ADRA1B—Signaling Pathways—MMP3—coronary artery disease	0.000114	0.000117	CbGpPWpGaD
Dapiprazole—ADRA1A—Signaling by GPCR—POMC—coronary artery disease	0.000114	0.000117	CbGpPWpGaD
Dapiprazole—ADRA1A—Signaling by GPCR—CREB1—coronary artery disease	0.000114	0.000117	CbGpPWpGaD
Dapiprazole—ADRA1A—Signaling Pathways—AGTR1—coronary artery disease	0.000114	0.000116	CbGpPWpGaD
Dapiprazole—ADRA1A—Signaling by GPCR—CCL2—coronary artery disease	0.000112	0.000114	CbGpPWpGaD
Dapiprazole—ADRA1A—Signaling by GPCR—IL6R—coronary artery disease	0.000111	0.000114	CbGpPWpGaD
Dapiprazole—ADRA1A—Signaling Pathways—CXCL10—coronary artery disease	0.000111	0.000114	CbGpPWpGaD
Dapiprazole—ADRA1A—Signaling Pathways—PLG—coronary artery disease	0.000111	0.000113	CbGpPWpGaD
Dapiprazole—ADRA1B—Signaling Pathways—APOB—coronary artery disease	0.00011	0.000113	CbGpPWpGaD
Dapiprazole—ADRA1B—GPCR downstream signaling—CXCL8—coronary artery disease	0.00011	0.000112	CbGpPWpGaD
Dapiprazole—ADRA1D—Signaling Pathways—HIF1A—coronary artery disease	0.000109	0.000111	CbGpPWpGaD
Dapiprazole—ADRA1B—Signaling by GPCR—JAK2—coronary artery disease	0.000109	0.000111	CbGpPWpGaD
Dapiprazole—ADRA1D—Signaling Pathways—AGT—coronary artery disease	0.000109	0.000111	CbGpPWpGaD
Dapiprazole—ADRA1B—Signaling Pathways—EDN1—coronary artery disease	0.000109	0.000111	CbGpPWpGaD
Dapiprazole—ADRA1A—Signaling Pathways—ADRB2—coronary artery disease	0.000108	0.00011	CbGpPWpGaD
Dapiprazole—ADRA1B—Signaling Pathways—CCL5—coronary artery disease	0.000108	0.00011	CbGpPWpGaD
Dapiprazole—ADRA1A—Signaling Pathways—PRKCE—coronary artery disease	0.000107	0.000109	CbGpPWpGaD
Dapiprazole—ADRA1A—GPCR downstream signaling—JAK2—coronary artery disease	0.000107	0.000109	CbGpPWpGaD
Dapiprazole—ADRA1D—Signaling Pathways—APOE—coronary artery disease	0.000107	0.000109	CbGpPWpGaD
Dapiprazole—ADRA1D—Signaling Pathways—LEP—coronary artery disease	0.000107	0.000109	CbGpPWpGaD
Dapiprazole—ADRA1A—Signaling Pathways—SOCS1—coronary artery disease	0.000106	0.000109	CbGpPWpGaD
Dapiprazole—ADRA1B—Signaling Pathways—CSF2—coronary artery disease	0.000106	0.000109	CbGpPWpGaD
Dapiprazole—ADRA1B—Signaling Pathways—FGF1—coronary artery disease	0.000106	0.000109	CbGpPWpGaD
Dapiprazole—ADRA1A—Signaling Pathways—S100B—coronary artery disease	0.000106	0.000108	CbGpPWpGaD
Dapiprazole—ADRA1B—Signaling Pathways—LPL—coronary artery disease	0.000105	0.000108	CbGpPWpGaD
Dapiprazole—ADRA1D—Signaling Pathways—APOA1—coronary artery disease	0.000105	0.000108	CbGpPWpGaD
Dapiprazole—ADRA1A—Signaling Pathways—SOCS3—coronary artery disease	0.000105	0.000107	CbGpPWpGaD
Dapiprazole—ADRA1B—Signaling Pathways—MEF2C—coronary artery disease	0.000105	0.000107	CbGpPWpGaD
Dapiprazole—ADRA1B—Signaling Pathways—RPS6KB1—coronary artery disease	0.000105	0.000107	CbGpPWpGaD
Dapiprazole—ADRA1D—Signaling Pathways—KDR—coronary artery disease	0.000104	0.000107	CbGpPWpGaD
Dapiprazole—ADRA1A—Signaling Pathways—TGFBR2—coronary artery disease	0.000104	0.000106	CbGpPWpGaD
Dapiprazole—ADRA1A—Signaling Pathways—KITLG—coronary artery disease	0.000104	0.000106	CbGpPWpGaD
Dapiprazole—ADRA1D—Signaling Pathways—MAPK14—coronary artery disease	0.000104	0.000106	CbGpPWpGaD
Dapiprazole—ADRA1B—Signaling Pathways—ITGB3—coronary artery disease	0.000102	0.000104	CbGpPWpGaD
Dapiprazole—ADRA1D—Signaling Pathways—ESR1—coronary artery disease	0.000102	0.000104	CbGpPWpGaD
Dapiprazole—ADRA1A—Signaling Pathways—MMP3—coronary artery disease	0.000102	0.000104	CbGpPWpGaD
Dapiprazole—ADRA1A—Signaling Pathways—STAT5A—coronary artery disease	0.000102	0.000104	CbGpPWpGaD
Dapiprazole—ADRA1D—Signaling Pathways—F2—coronary artery disease	0.0001	0.000103	CbGpPWpGaD
Dapiprazole—ADRA1D—Signaling Pathways—FN1—coronary artery disease	0.0001	0.000103	CbGpPWpGaD
Dapiprazole—ADRA1D—Signaling Pathways—IL6ST—coronary artery disease	0.0001	0.000102	CbGpPWpGaD
Dapiprazole—ADRA1B—Signaling by GPCR—CXCL8—coronary artery disease	9.95e-05	0.000102	CbGpPWpGaD
Dapiprazole—ADRA1D—Signaling Pathways—NFKBIA—coronary artery disease	9.93e-05	0.000101	CbGpPWpGaD
Dapiprazole—ADRA1B—Signaling Pathways—PPP2CA—coronary artery disease	9.9e-05	0.000101	CbGpPWpGaD
Dapiprazole—ADRA1A—Signaling Pathways—APOB—coronary artery disease	9.81e-05	0.0001	CbGpPWpGaD
Dapiprazole—ADRA1A—GPCR downstream signaling—CXCL8—coronary artery disease	9.73e-05	9.93e-05	CbGpPWpGaD
Dapiprazole—ADRA1B—Signaling Pathways—PRKCD—coronary artery disease	9.72e-05	9.92e-05	CbGpPWpGaD
Dapiprazole—ADRA1A—Signaling by GPCR—JAK2—coronary artery disease	9.68e-05	9.89e-05	CbGpPWpGaD
Dapiprazole—ADRA1A—Signaling Pathways—EDN1—coronary artery disease	9.66e-05	9.86e-05	CbGpPWpGaD
Dapiprazole—ADRA1D—Signaling Pathways—KIT—coronary artery disease	9.61e-05	9.82e-05	CbGpPWpGaD
Dapiprazole—ADRA1A—Signaling Pathways—CCL5—coronary artery disease	9.58e-05	9.78e-05	CbGpPWpGaD
Dapiprazole—ADRA1B—Signaling Pathways—HTR2A—coronary artery disease	9.51e-05	9.71e-05	CbGpPWpGaD
Dapiprazole—ADRA1B—Signaling Pathways—C3—coronary artery disease	9.5e-05	9.7e-05	CbGpPWpGaD
Dapiprazole—ADRA1A—Signaling Pathways—CSF2—coronary artery disease	9.44e-05	9.64e-05	CbGpPWpGaD
Dapiprazole—ADRA1A—Signaling Pathways—FGF1—coronary artery disease	9.44e-05	9.64e-05	CbGpPWpGaD
Dapiprazole—ADRA1A—Signaling Pathways—LPL—coronary artery disease	9.37e-05	9.57e-05	CbGpPWpGaD
Dapiprazole—ADRA1A—Signaling Pathways—MEF2C—coronary artery disease	9.29e-05	9.48e-05	CbGpPWpGaD
Dapiprazole—ADRA1A—Signaling Pathways—RPS6KB1—coronary artery disease	9.29e-05	9.48e-05	CbGpPWpGaD
Dapiprazole—ADRA1D—Signaling Pathways—GSK3B—coronary artery disease	9.23e-05	9.42e-05	CbGpPWpGaD
Dapiprazole—ADRA1D—Signaling Pathways—POMC—coronary artery disease	9.15e-05	9.35e-05	CbGpPWpGaD
Dapiprazole—ADRA1D—Signaling Pathways—CREB1—coronary artery disease	9.15e-05	9.35e-05	CbGpPWpGaD
Dapiprazole—ADRA1B—Signaling Pathways—HIF1A—coronary artery disease	9.06e-05	9.25e-05	CbGpPWpGaD
Dapiprazole—ADRA1A—Signaling Pathways—ITGB3—coronary artery disease	9.05e-05	9.24e-05	CbGpPWpGaD
Dapiprazole—ADRA1B—Signaling Pathways—AGT—coronary artery disease	9.02e-05	9.21e-05	CbGpPWpGaD
Dapiprazole—ADRA1D—Signaling Pathways—CCL2—coronary artery disease	8.95e-05	9.14e-05	CbGpPWpGaD
Dapiprazole—ADRA1D—Signaling Pathways—IL6R—coronary artery disease	8.93e-05	9.12e-05	CbGpPWpGaD
Dapiprazole—ADRA1B—Signaling Pathways—APOE—coronary artery disease	8.84e-05	9.03e-05	CbGpPWpGaD
Dapiprazole—ADRA1B—Signaling Pathways—LEP—coronary artery disease	8.84e-05	9.03e-05	CbGpPWpGaD
Dapiprazole—ADRA1A—Signaling by GPCR—CXCL8—coronary artery disease	8.83e-05	9.02e-05	CbGpPWpGaD
Dapiprazole—ADRA1D—Signaling Pathways—IGF1—coronary artery disease	8.8e-05	8.99e-05	CbGpPWpGaD
Dapiprazole—ADRA1A—Signaling Pathways—PPP2CA—coronary artery disease	8.79e-05	8.98e-05	CbGpPWpGaD
Dapiprazole—ADRA1D—Signaling by GPCR—MAPK1—coronary artery disease	8.76e-05	8.95e-05	CbGpPWpGaD
Dapiprazole—ADRA1B—Signaling Pathways—APOA1—coronary artery disease	8.74e-05	8.93e-05	CbGpPWpGaD
Dapiprazole—ADRA1B—Signaling Pathways—KDR—coronary artery disease	8.66e-05	8.85e-05	CbGpPWpGaD
Dapiprazole—ADRA1A—Signaling Pathways—PRKCD—coronary artery disease	8.63e-05	8.82e-05	CbGpPWpGaD
Dapiprazole—ADRA1B—Signaling Pathways—MAPK14—coronary artery disease	8.61e-05	8.79e-05	CbGpPWpGaD
Dapiprazole—ADRA1A—Signaling Pathways—HTR2A—coronary artery disease	8.45e-05	8.63e-05	CbGpPWpGaD
Dapiprazole—ADRA1B—Signaling Pathways—ESR1—coronary artery disease	8.44e-05	8.62e-05	CbGpPWpGaD
Dapiprazole—ADRA1A—Signaling Pathways—C3—coronary artery disease	8.44e-05	8.61e-05	CbGpPWpGaD
Dapiprazole—ADRA1D—GPCR downstream signaling—PIK3CA—coronary artery disease	8.37e-05	8.55e-05	CbGpPWpGaD
Dapiprazole—ADRA1D—Signaling Pathways—SERPINE1—coronary artery disease	8.36e-05	8.54e-05	CbGpPWpGaD
Dapiprazole—ADRA1B—Signaling Pathways—FN1—coronary artery disease	8.34e-05	8.51e-05	CbGpPWpGaD
Dapiprazole—ADRA1B—Signaling Pathways—F2—coronary artery disease	8.34e-05	8.51e-05	CbGpPWpGaD
Dapiprazole—ADRA1B—Signaling Pathways—IL6ST—coronary artery disease	8.3e-05	8.48e-05	CbGpPWpGaD
Dapiprazole—ADRA1B—Signaling Pathways—NFKBIA—coronary artery disease	8.24e-05	8.41e-05	CbGpPWpGaD
Dapiprazole—ADRA1D—Signaling Pathways—FGF2—coronary artery disease	8.09e-05	8.26e-05	CbGpPWpGaD
Dapiprazole—ADRA1A—Signaling Pathways—HIF1A—coronary artery disease	8.05e-05	8.22e-05	CbGpPWpGaD
Dapiprazole—ADRA1A—Signaling Pathways—AGT—coronary artery disease	8.02e-05	8.19e-05	CbGpPWpGaD
Dapiprazole—ADRA1D—Signaling Pathways—NOS3—coronary artery disease	7.98e-05	8.15e-05	CbGpPWpGaD
Dapiprazole—ADRA1B—Signaling Pathways—KIT—coronary artery disease	7.98e-05	8.15e-05	CbGpPWpGaD
Dapiprazole—ADRA1A—Signaling Pathways—LEP—coronary artery disease	7.85e-05	8.02e-05	CbGpPWpGaD
Dapiprazole—ADRA1A—Signaling Pathways—APOE—coronary artery disease	7.85e-05	8.02e-05	CbGpPWpGaD
Dapiprazole—ADRA1A—Signaling Pathways—APOA1—coronary artery disease	7.76e-05	7.93e-05	CbGpPWpGaD
Dapiprazole—ADRA1D—Signaling Pathways—JAK2—coronary artery disease	7.76e-05	7.92e-05	CbGpPWpGaD
Dapiprazole—ADRA1A—Signaling Pathways—KDR—coronary artery disease	7.69e-05	7.86e-05	CbGpPWpGaD
Dapiprazole—ADRA1B—Signaling Pathways—GSK3B—coronary artery disease	7.66e-05	7.82e-05	CbGpPWpGaD
Dapiprazole—ADRA1A—Signaling Pathways—MAPK14—coronary artery disease	7.64e-05	7.81e-05	CbGpPWpGaD
Dapiprazole—ADRA1D—Signaling by GPCR—PIK3CA—coronary artery disease	7.6e-05	7.76e-05	CbGpPWpGaD
Dapiprazole—ADRA1B—Signaling Pathways—POMC—coronary artery disease	7.6e-05	7.76e-05	CbGpPWpGaD
Dapiprazole—ADRA1B—Signaling Pathways—CREB1—coronary artery disease	7.6e-05	7.76e-05	CbGpPWpGaD
Dapiprazole—ADRA1A—Signaling Pathways—ESR1—coronary artery disease	7.5e-05	7.66e-05	CbGpPWpGaD
Dapiprazole—ADRA1B—Signaling Pathways—CCL2—coronary artery disease	7.43e-05	7.59e-05	CbGpPWpGaD
Dapiprazole—ADRA1B—Signaling Pathways—IL6R—coronary artery disease	7.41e-05	7.57e-05	CbGpPWpGaD
Dapiprazole—ADRA1A—Signaling Pathways—F2—coronary artery disease	7.41e-05	7.56e-05	CbGpPWpGaD
Dapiprazole—ADRA1A—Signaling Pathways—FN1—coronary artery disease	7.41e-05	7.56e-05	CbGpPWpGaD
Dapiprazole—ADRA1A—Signaling Pathways—IL6ST—coronary artery disease	7.38e-05	7.53e-05	CbGpPWpGaD
Dapiprazole—ADRA1A—Signaling Pathways—NFKBIA—coronary artery disease	7.32e-05	7.47e-05	CbGpPWpGaD
Dapiprazole—ADRA1B—Signaling Pathways—IGF1—coronary artery disease	7.31e-05	7.46e-05	CbGpPWpGaD
Dapiprazole—ADRA1B—Signaling by GPCR—MAPK1—coronary artery disease	7.27e-05	7.43e-05	CbGpPWpGaD
Dapiprazole—ADRA1A—Signaling Pathways—KIT—coronary artery disease	7.09e-05	7.24e-05	CbGpPWpGaD
Dapiprazole—ADRA1D—Signaling Pathways—CXCL8—coronary artery disease	7.08e-05	7.23e-05	CbGpPWpGaD
Dapiprazole—ADRA1B—GPCR downstream signaling—PIK3CA—coronary artery disease	6.95e-05	7.1e-05	CbGpPWpGaD
Dapiprazole—ADRA1B—Signaling Pathways—SERPINE1—coronary artery disease	6.94e-05	7.08e-05	CbGpPWpGaD
Dapiprazole—ADRA1D—GPCR downstream signaling—AKT1—coronary artery disease	6.84e-05	6.98e-05	CbGpPWpGaD
Dapiprazole—ADRA1A—Signaling Pathways—GSK3B—coronary artery disease	6.8e-05	6.95e-05	CbGpPWpGaD
Dapiprazole—ADRA1D—Signaling Pathways—CASP3—coronary artery disease	6.78e-05	6.92e-05	CbGpPWpGaD
Dapiprazole—ADRA1A—Signaling Pathways—POMC—coronary artery disease	6.75e-05	6.89e-05	CbGpPWpGaD
Dapiprazole—ADRA1A—Signaling Pathways—CREB1—coronary artery disease	6.75e-05	6.89e-05	CbGpPWpGaD
Dapiprazole—ADRA1D—Signaling by GPCR—IL6—coronary artery disease	6.73e-05	6.87e-05	CbGpPWpGaD
Dapiprazole—ADRA1B—Signaling Pathways—FGF2—coronary artery disease	6.72e-05	6.86e-05	CbGpPWpGaD
Dapiprazole—ADRA1B—Signaling Pathways—NOS3—coronary artery disease	6.62e-05	6.76e-05	CbGpPWpGaD
Dapiprazole—ADRA1A—Signaling Pathways—CCL2—coronary artery disease	6.6e-05	6.74e-05	CbGpPWpGaD
Dapiprazole—ADRA1D—Signaling Pathways—CCND1—coronary artery disease	6.6e-05	6.73e-05	CbGpPWpGaD
Dapiprazole—ADRA1A—Signaling Pathways—IL6R—coronary artery disease	6.58e-05	6.72e-05	CbGpPWpGaD
Dapiprazole—ADRA1A—Signaling Pathways—IGF1—coronary artery disease	6.49e-05	6.63e-05	CbGpPWpGaD
Dapiprazole—ADRA1A—Signaling by GPCR—MAPK1—coronary artery disease	6.46e-05	6.6e-05	CbGpPWpGaD
Dapiprazole—ADRA1B—Signaling Pathways—JAK2—coronary artery disease	6.44e-05	6.57e-05	CbGpPWpGaD
Dapiprazole—ADRA1D—Signaling Pathways—MMP9—coronary artery disease	6.4e-05	6.54e-05	CbGpPWpGaD
Dapiprazole—ADRA1B—Signaling by GPCR—PIK3CA—coronary artery disease	6.31e-05	6.44e-05	CbGpPWpGaD
Dapiprazole—ADRA1D—Signaling by GPCR—AKT1—coronary artery disease	6.21e-05	6.34e-05	CbGpPWpGaD
Dapiprazole—ADRA1A—GPCR downstream signaling—PIK3CA—coronary artery disease	6.17e-05	6.3e-05	CbGpPWpGaD
Dapiprazole—ADRA1A—Signaling Pathways—SERPINE1—coronary artery disease	6.16e-05	6.29e-05	CbGpPWpGaD
Dapiprazole—ADRA1A—Signaling Pathways—FGF2—coronary artery disease	5.97e-05	6.09e-05	CbGpPWpGaD
Dapiprazole—ADRA1A—Signaling Pathways—NOS3—coronary artery disease	5.88e-05	6.01e-05	CbGpPWpGaD
Dapiprazole—ADRA1B—Signaling Pathways—CXCL8—coronary artery disease	5.88e-05	6e-05	CbGpPWpGaD
Dapiprazole—ADRA1D—Signaling Pathways—VEGFA—coronary artery disease	5.75e-05	5.87e-05	CbGpPWpGaD
Dapiprazole—ADRA1A—Signaling Pathways—JAK2—coronary artery disease	5.72e-05	5.84e-05	CbGpPWpGaD
Dapiprazole—ADRA1B—GPCR downstream signaling—AKT1—coronary artery disease	5.68e-05	5.8e-05	CbGpPWpGaD
Dapiprazole—ADRA1B—Signaling Pathways—CASP3—coronary artery disease	5.62e-05	5.74e-05	CbGpPWpGaD
Dapiprazole—ADRA1A—Signaling by GPCR—PIK3CA—coronary artery disease	5.6e-05	5.72e-05	CbGpPWpGaD
Dapiprazole—ADRA1B—Signaling by GPCR—IL6—coronary artery disease	5.59e-05	5.71e-05	CbGpPWpGaD
Dapiprazole—ADRA1B—Signaling Pathways—CCND1—coronary artery disease	5.47e-05	5.59e-05	CbGpPWpGaD
Dapiprazole—ADRA1B—Signaling Pathways—MMP9—coronary artery disease	5.31e-05	5.43e-05	CbGpPWpGaD
Dapiprazole—ADRA1D—Signaling Pathways—TGFB1—coronary artery disease	5.28e-05	5.39e-05	CbGpPWpGaD
Dapiprazole—ADRA1A—Signaling Pathways—CXCL8—coronary artery disease	5.22e-05	5.33e-05	CbGpPWpGaD
Dapiprazole—ADRA1D—Signaling Pathways—MAPK1—coronary artery disease	5.18e-05	5.28e-05	CbGpPWpGaD
Dapiprazole—ADRA1B—Signaling by GPCR—AKT1—coronary artery disease	5.15e-05	5.26e-05	CbGpPWpGaD
Dapiprazole—ADRA1A—GPCR downstream signaling—AKT1—coronary artery disease	5.04e-05	5.15e-05	CbGpPWpGaD
Dapiprazole—ADRA1A—Signaling Pathways—CASP3—coronary artery disease	5e-05	5.1e-05	CbGpPWpGaD
Dapiprazole—ADRA1A—Signaling by GPCR—IL6—coronary artery disease	4.96e-05	5.07e-05	CbGpPWpGaD
Dapiprazole—ADRA1A—Signaling Pathways—CCND1—coronary artery disease	4.86e-05	4.97e-05	CbGpPWpGaD
Dapiprazole—ADRA1B—Signaling Pathways—VEGFA—coronary artery disease	4.77e-05	4.87e-05	CbGpPWpGaD
Dapiprazole—ADRA1A—Signaling Pathways—MMP9—coronary artery disease	4.72e-05	4.82e-05	CbGpPWpGaD
Dapiprazole—ADRA1A—Signaling by GPCR—AKT1—coronary artery disease	4.58e-05	4.68e-05	CbGpPWpGaD
Dapiprazole—ADRA1D—Signaling Pathways—PIK3CA—coronary artery disease	4.49e-05	4.59e-05	CbGpPWpGaD
Dapiprazole—ADRA1B—Signaling Pathways—TGFB1—coronary artery disease	4.38e-05	4.47e-05	CbGpPWpGaD
Dapiprazole—ADRA1B—Signaling Pathways—MAPK1—coronary artery disease	4.3e-05	4.39e-05	CbGpPWpGaD
Dapiprazole—ADRA1A—Signaling Pathways—VEGFA—coronary artery disease	4.24e-05	4.33e-05	CbGpPWpGaD
Dapiprazole—ADRA1D—Signaling Pathways—IL6—coronary artery disease	3.98e-05	4.06e-05	CbGpPWpGaD
Dapiprazole—ADRA1A—Signaling Pathways—TGFB1—coronary artery disease	3.89e-05	3.97e-05	CbGpPWpGaD
Dapiprazole—ADRA1A—Signaling Pathways—MAPK1—coronary artery disease	3.82e-05	3.9e-05	CbGpPWpGaD
Dapiprazole—ADRA1B—Signaling Pathways—PIK3CA—coronary artery disease	3.73e-05	3.81e-05	CbGpPWpGaD
Dapiprazole—ADRA1D—Signaling Pathways—AKT1—coronary artery disease	3.67e-05	3.75e-05	CbGpPWpGaD
Dapiprazole—ADRA1A—Signaling Pathways—PIK3CA—coronary artery disease	3.31e-05	3.38e-05	CbGpPWpGaD
Dapiprazole—ADRA1B—Signaling Pathways—IL6—coronary artery disease	3.3e-05	3.37e-05	CbGpPWpGaD
Dapiprazole—ADRA1B—Signaling Pathways—AKT1—coronary artery disease	3.04e-05	3.11e-05	CbGpPWpGaD
Dapiprazole—ADRA1A—Signaling Pathways—IL6—coronary artery disease	2.93e-05	2.99e-05	CbGpPWpGaD
Dapiprazole—ADRA1A—Signaling Pathways—AKT1—coronary artery disease	2.7e-05	2.76e-05	CbGpPWpGaD
